Work

A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer

Year: 2011

Type: article

Study design: Clinical Trial

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2011.05.005

Authors: Paul K. Paik, Charles M. Rudin, Maria C. Pietanza, Andrew Brown, Naiyer A. Rizvi, Naoko Takebe, William Travis, Leonard James, Michelle S. Ginsberg, Rosalyn Juergens, Susan Markus, Leslie Tyson, Sara Subzwari, Mark G. Kris, Lee M. Krug

Institutions: Memorial Sloan Kettering Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, National Cancer Institute

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: GlaxoSmithKline, National Institutes of Health, Genentech, National Cancer Institute

Awards: G1165598027, Phase I Clinical Trials of New Anti-Cancer Targeted Therapies, G2726538198, G455788110

OpenAlex ID: W2096495293

FWCI: 4.96

Cites: 26

Cited by: 98

Related to: 10